John Klein - Founder of Cambridge Therapeutics

0 Seguidores

The founder of Cambridge Therapeutics and Dava Pharmaceutical Company, John Klein draws on more than two decades of experience in the pharmaceutical industry. After graduating from Roosevelt University with a BS and an MBA in finance, he began receiving recognition for his work, which included Corporate Turnaround of the Year honors from Business Week for his leadership at Zenith Laboratories, Inc. John Klein’s work in the area of improving shareholder value also earned him 11th place on Forbes’ Top 100 CEOs list. In addition to his current endeavors as the chairman and CEO of Cambridge Therapeutics,

john klein cambridge therapeutics cambridge therapeutics john klein enterprise performance management new jersey epm bilogix performance management financial planning framework methodology epm solution chain effectiveness aberdeen annual survey software market projected growth epm operational performance solutions nj alpine kpis business strategy together hospital insurance company concern rare virus conditions improve psychiatric institutions stem-based learning dwight-englewood school roosevelt psychology and business master’s degrees generic medications packaging code of federal regulations

Actividad
Acerca de

John Klein - Founder of Cambridge Therapeutics

Presentaciones

Appearance of Rare Virus Causes Concern Among New Jersey Public

New Jersey’s Largest Insurance Company and Hospital Join Together

What Can Enterprise Performance Management Do for Your Business?

Bilogix - Provider of Enterprise Performance Management Solutions

Aberdeen Annual Survey Highlights Effectiveness of EPM

The EPM Solution Chain

Understanding the cognizant approach to epm